Skip to main content

Table 2 Unadjusted and adjusted time ratio (TR) for survival time using Log-Logistic regression analysis, with and without unobserved heterogeneity (“frailty”)

From: Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users

 

Model 1: total population

Model 2: total population

Model 3: womena

Model 4: mena

No frailtya

Frailtyb

Unadjusted

Adjusted

Adjusted

Adjusted

Adjusted

TRc[95% CI]

TRc[95% CI]

TRc[95% CI]

TRc[95% CI]

TRc[95% CI]

Male

0.5 [0.2, 1.7]

0.5 [0.1, 1.7]

0.5 [0.1, 1.7]

-

 

≥ 30 yearsd

0.8 [0.3, 2.1]

0.8 [0.3, 2.3]

0.8 [0.3, 2.3]

0.1 [0.0, 4.5]

1.3 [0.5, 3.6]

> 5 years IV careere

0.8 [0.2, 2.7]

1.1 [0.3, 3.8]

1.1 [0.3, 3.8]

1.0 [0.0, 152.3]

1.1 [0.3, 3.7]

Combined heroin and prescription drugsf, g

0.4 [0.2, 1.1]*

0.4 [0.1, 1.0]*

0.4 [0.1, 1.0]*

0.2 [0.0, 5.3]

0.5 [0.2, 1.2]

Alcohol ≥2 days a weekg

0.8 [0.3, 2.3]

0.8 [0.3, 2.4]

0.8 [0.3, 2.4]

0.3 [0.0, 11.8]

0.8 [0.3, 2.3]

Sex workg

0.4 [0.1, 1.7]

-

-

0.02 [0.00, 1.8]*

-

n

171

171

171

43

128

Gamma

-

1.4 [1.0, 1.8]

1.4 [1.0, 1.8]

1.8 [1.0, 3.4]

1.2 [0.9, 1.6]

Theta

-

-

0

-

-

Log-Likelihood

-

-161.7

-161.7

-30.7

-125.2

Akaike’s Info. Crit.

-

337.5

339.5

75.4

70.7

Likelihood-ratio test of theta = 0

-

-

0.0 p = 1.000

-

-

  1. *p < 0.10.
  2. aWithout unobserved heterogeneity.
  3. bWith unobserved heterogeneity.
  4. cTime ratio for covariate k = exp (β*k).
  5. dAt inclusion.
  6. e> 5 years between first injection and interview.
  7. fCombined heroin and prescription drugs in injections.
  8. gIn the previous four weeks before the baseline interview.